Evaluation of an Online, On Demand Multimodal Wellness Program to Reduce Fatigue and Improve Quality of Life in Progressive Multiple Sclerosis.
Part of paid clinical trials in Iowa City, Iowa.
- Sponsor
- University of Iowa
- Study ID
- NCT07831928
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Primary Progressive Multiple Sclerosis (PPMS)
- Secondary Progressive Multiple Sclerosis (SPMS)
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Online wellness course and online exercise platform — BEHAVIORALAn online wellness course that teaches participants about behavior change, nutrition, exercise, stress management, and other wellness behaviors. Also includes access to an online exercise platform.
- Usual Care Group — OTHERParticipant will continue with their usual diet and wellness behaviors.
Study Details
The goal of this clinical trial is to learn if an online wellness program can lower fatigue and improve mood and quality of life in people with progressive multiple sclerosis who are 45 to 70 years old and are experiencing significant fatigue disability. The main questions it aims to answer are: * Does the online wellness program lower fatigue after 3 months and further lower fatigue after 6 months? * Does the online wellness program improve anxiety, depression, and quality of life after 3 months and lead to additional improvements after 6 months? Researchers will compare participants who receive immediate access to the online wellness program with participants who continue their usual care and receive access to the program after the study ends. Participants will: * Complete online surveys at the start of the study, at 3 months, and at 6 months. Each survey session takes less than 1 hour. * Complete a 7-day run-in period before randomization to confirm their interest and ability to complete study activities. * Be assigned by chance to either the online wellness program group or the wait-list control group. Participants in the online wellness program group will: * Receive access to the "Creating Health" online course through the University of Iowa Canvas platform. * Work through five self-paced education modules over 6 months. Topics include nutrition, stress management, and physical activity. * Have access to monthly group coaching calls by Zoom. * Have access to an online exercise platform. * Have access to email and text support from the study team. Participants in the wait-list control group will: * Continue their usual diet, lifestyle, and medical care during the 6-month study period. * Complete the same study surveys as the intervention group. * Receive full access to the online wellness program, online exercise platform and support materials after completing their final 6-month surveys. At the end of the study, all participants will complete final surveys about their symptoms, quality of life, and their experience with the program. Active study participation ends after the 6-month assessments are completed.
Key Dates
- First listed
- Sep 21, 2026
- Start date
- Nov 15, 2026
- Status verified
- Sep 2026
- Primary completion
- Nov 15, 2029
- Completion
- Dec 15, 2030
Study Design
- Enrollment
- 118 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention armWellness online program and virtual exercise platform
- Placebo Comparator: Waitlist controlContinues with usual care as directed by their neurologist
Primary Outcome Measure
Fatigue Severity Scale (FSS) Score [ Time Frame: Baseline to 3 months ]
Central Contacts
- Mary Ehlinger, BS319 3845002
- Whitney Schley, Schley3193568555
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UI Health Care | Iowa City | Iowa | 52242. | - |
Find similar trials in Iowa City, IA
Related Studies
- Study of NG01 Cell Therapy in Secondary Progressive Multiple SclerosisPHASE2 · Not Yet Recruiting · NeuroGenesis Ltd. · Miami, Florida
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPHASE3 · Recruiting · Novartis Pharmaceuticals · Birmingham, Alabama
- Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisPHASE1/PHASE2 · Recruiting · Tr1X, Inc. · La Jolla, California